Sign Out
Allergic reactions to Mycophenolate mofetil (CellCept) have been observed. Therefore, Mycophenolate mofetil (CellCept) is contraindicated in patients with a known hypersensitivity to mycophenolate mofetil or mycophenolic acid (MPA). Mycophenolate mofetil (CellCept) i.v. is also contraindicated in patients with known hypersensitivity to polysorbate 80.
Mycophenolate mofetil (CellCept) is contraindicated during pregnancy due to its mutagenic and teratogenic potential (see Pregnancy under Use in Pregnancy & Lactation).
Mycophenolate mofetil (CellCept) is contraindicated in women of childbearing potential not using highly effective contraceptive methods (see Females and Males of Reproductive Potential under Use in Pregnancy & Lactation).
Mycophenolate mofetil (CellCept) is contraindicated in women who are breastfeeding (see Lactation under Use in Pregnancy & Lactation).
Continue with Google